Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
The following is a summary of the NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript:
以下是NeueHealth, Inc.（NEUE）2024年第一季度财报电话会议记录摘要：
Financial Performance:
财务业绩：
NeueHealth reported a consolidated Q1 revenue of $245.1 million, slightly below expectations due to lower NeueCare volume and ACO business development.
The company delivered a gross margin of $48.2 million and a quarterly adjusted EBITDA of $2.5 million.
NeueCare segment revenue was $73.6 million with an operating income of $9.8 million.
The NeueSolution segment posted revenue of $173.9 million and an operating loss of $2.9 million.
NeueHealth报告称，由于NeueCare销量下降和ACO业务发展，第一季度合并收入为2.451亿美元，略低于预期。
该公司的毛利率为4,820万美元，季度调整后的息税折旧摊销前利润为250万美元。
NeueCare板块收入为7,360万美元，营业收入为980万美元。
NeueSolution板块公布的收入为1.739亿美元，营业亏损为290万美元。
Business Progress:
业务进展：
The NeueCare segment has expanded in Central Florida, adding 41,000 more consumers with plans for further expansions in 2024 and beyond.
NeueHealth served a total of 469,000 consumers across the NeueCare and NeueSolution segments in Q1 2024.
Growth in partnerships within the NeueSolution segment marks it as a key driver for the future.
The company serves approximately 40% of the 745,000 ACA marketplace consumers in the Miami-Dade market, receiving high customer satisfaction scores.
The company aims to serve between 475,000 and 500,000 consumers across both segments by the end of 2024, focusing on a value-driven, consumer-centric care model.
NeueCare细分市场已在佛罗里达州中部扩张，增加了41,000名消费者，并计划在2024年及以后进一步扩张。
2024年第一季度，NeueHealth为NeueCare和NeueSolution领域的共计46.9万名消费者提供了服务。
NeueSolution细分市场内部合作伙伴关系的增长标志着其成为未来的关键驱动力。
该公司为迈阿密戴德市场74.5万名ACA市场消费者中的约40％提供服务，获得了很高的客户满意度分数。
该公司的目标是到2024年底为这两个细分市场的47.5万至50万名消费者提供服务，重点是价值驱动、以消费者为中心的护理模式。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多详情，请访问投资者关系网站。本文仅供投资者参考，不构成任何投资建议。
译文内容由第三方软件翻译。